{"schema_version":"secwatch.filing_event.v1","accession":"0001826466-24-000128","form_type":"8-K","ticker":"NIKA","cik":"0001145604","company_name":"NIKA PHARMACEUTICALS, INC","filed_at":"2024-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.796714+00:00","generated_at":"2026-05-30T23:02:43.516729+00:00","sec_items":["4.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Nika Pharmaceuticals hires OLAYINKA OYEBOLA & CO as new auditor","bullets":["Engaged OLAYINKA OYEBOLA & CO (Chartered Accountants) as independent auditor on September 23, 2024.","Firm will audit the company's financial statements going forward.","No mention of predecessor auditor or any accounting disagreements in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001826466-24-000128","json":"https://secwatch.observer/filing/0001826466-24-000128.json","markdown":"https://secwatch.observer/filing/0001826466-24-000128.md","text":"https://secwatch.observer/filing/0001826466-24-000128.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1145604/000182646624000128/0001826466-24-000128-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1145604/000182646624000128/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T23:02:43.516729+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}